Two Blood Signals Diverge Early and Refine Liver Cancer Therapy Response
For patients with hepatocellular carcinoma, the first weeks of treatment are a diagnostic gray zone. The tumor is too large...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
For patients with hepatocellular carcinoma, the first weeks of treatment are a diagnostic gray zone. The tumor is too large...
A new reproducible benchmark called REACH evaluates ten computational methods for detecting rare malignant cells in single-cell RNA sequencing data,...
A phenomenological study of 20 oncology nurses at a major Ghanaian referral hospital reveals how they navigate belief differences, existential...
Chemists isolated a never-before-seen lupane triterpene and a leukemia-selective compound from the branches of a traditional Brazilian medicinal shrub.
A new interpretable AI model called PRISM combines pathology slides with transcriptomic pathway data to sharpen progression-risk prediction in early-stage...
A new review outlines how drug-tolerant persister cells hidden within minimal residual disease drive cancer relapse and how pathway inhibitors,...
A multicountry survey of over 1,000 university students in Jordan, Egypt, and Saudi Arabia found only moderate colorectal cancer awareness,...
A retrospective cohort study of 96 patients shows the CAR-HEMATOTOX score predicts severe neutropenia and thrombocytopenia after CAR-T cell therapy,...
A systematic bibliometric review of more than 3,200 publications reveals that tumor immunometabolism research has surged since 2020, shifting from...
A seven-year national analysis finds blood clots in nearly 5% of hospitalized acute leukemia patients, with rising prevalence and a...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine